Press Releases and Statements

Browse Press Releases and Statements Content

The Consumer Healthcare Products Association (CHPA), the leading voice advocating to empower self-care by preserving and expanding access to trusted consumer healthcare products, today released the following statement in recognition of International Self-Care Day, which is recognized annually on July 24:

Jul 24, 2024

The Consumer Healthcare Products Association today released the following statement after joining 17 other members of the Health Choices Coalition – a group comprised of healthcare providers, patients, consumers, retailers, manufacturers, pharmacies, insurers, and businesses of all sizes – in sending a letter of support to sponsors of the Oral Health Products Inclusion Act (H.R. 8599). This legislation would increase access to everyday over-the-counter (OTC) oral care products by allowing them to be purchased with Flexible Spending Account (FSA) and Health Savings Account (HSA) funds as “qualified medical expenses.”

Jul 24, 2024

(WASHINGTON, D.C.) — Today, the Consumer Healthcare Products Association (CHPA), the national trade association representing the leading manufacturers and marketers of consumer healthcare products, announced the addition of 15 new members, four manufacturers and 11 associate members, from the last quarter. This continues a strong growth trajectory of diverse self-care companies joining the association. CHPA also recognized several of its member companies for reaching significant membership milestone anniversaries this year.

Jul 22, 2024

CHPA Senior Vice President of Legal, Government Affairs & Policy David Spangler released the below statement today following the U.S. Supreme Court’s decision to overturn the Chevron standard, a principle of judicial deference used by federal courts for nearly four decades when reviewing a federal agency’s interpretation of a statute it administers:

Jun 28, 2024

(WASHINGTON, D.C.) The Consumer Healthcare Products Association (CHPA) today announced the election of new members to its board of directors during the association’s summer meeting this week in Washington.

Jun 14, 2024

CHPA and several of its member companies who manufacture and market leading over-the-counter oral care products, including Colgate-Palmolive, Haleon, Kenvue, Lornamead, Procter & Gamble, and Sanofi, joined Members of Congress on Capitol Hill this week to celebrate the introduction of HR 8599, the Oral Health Products Inclusion Act. 

Jun 14, 2024

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the below statement today applauding the passage of H.R. 2964, the Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act in the U.S. House of Representatives.

Jun 11, 2024

CHPA released the following statement today applauding the introduction of HR 8599, the Oral Health Products Inclusion Act. This bipartisan legislation, sponsored by U.S. Reps. Jeff Van Drew (NJ-02), Brad Schneider (IL-10), Nicole Malliotakis (NY-11), and Jimmy Panetta (CA-19), would increase access to certain oral care items, including manual and electric toothbrushes, water flossers, anti-cavity toothpaste, mouthwash, and similar oral care products by recognizing them as “qualified medical expenses” that can be purchased with Flexible Spending Account (FSA) and Health Savings Account (HSA) funds. Extending eligibility to oral care products so Americans can better manage their unique oral care needs builds upon a previous bipartisan victory in 2020, which reinstated FSA/HSA eligibility for OTC medicines, and for the first time, feminine care products, as part of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Jun 4, 2024

(Washington, D.C.) – Today, the Consumer Healthcare Products Association (CHPA) released the following statement after submitting comments to the U.S. Food and Drug Administration (FDA) in response to draft guidance the Agency released in April on New Dietary Ingredient Notification (NDIN) Master Files for Dietary Supplements:

Jun 4, 2024

Washington, D.C. – The Consumer Healthcare Products Association (CHPA) today released the below statement following the announcement that the U.S. Food and Drug Administration (FDA) approved its reorganization efforts involving the creation of a unified Human Foods Program (HFP), adoption of a new model for its field operations, and other significant modernization efforts:

May 30, 2024

CHPA released the below statement today following Governor Phil Scott signing S. 187 into law this week, legislation that will allow students to carry and self-apply sunscreen at school with the permission of a parent or guardian.

May 8, 2024

CHPA released the below statement today following Tennessee Governor Bill Lee's recent signing of Senate Bill 2048 into law, legislation that raises the monthly purchase limit for common over-the-counter (OTC) cold and allergy medications containing the ingredient pseudoephedrine (PSE) from 5.76 grams per month to 7.2 grams, allowing access to a full 30-day supply per month. The bill also raises the annual purchase limit to 43.2 grams, which is a 40% increase from the current limit of 28.8 grams.

May 7, 2024

Filter Results